The Potential for EBV Vaccines to Prevent Multiple Sclerosis.

Front Neurol · 2022 · PMC9263514 · PMID 35812097

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A phase 1 study of an EBV peptide, derived from EBNA3A, in tetanus toxoid and oil and water emulsion, showed a trend in reduction of infectious mononucleosis ( 60 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.